About Respiri
Respiri is a company based in Melbourne (Australia) founded in 1987. Respiri offers products and services including WheezeRate Detector, RPM Programs, and Telehealth Platforms. Respiri operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
- Headquarter Melbourne, Australia
- Stage Public
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website respiri.co
- Social LinkedIn X
- Legal Name Vitasora Health Limited
- Annual Revenue$2.95 M (USD)38.59as on Jun 30, 2026
- Net Profit-$7.31 M (USD)0.86as on Jun 30, 2026
- EBITDA-$6.83 M (USD)6.97as on Jun 30, 2026
- Latest Funding Round$12.5M (USD), Post-IPO
Oct 2020
- Investors
Products & Services of Respiri
Respiri offers a comprehensive portfolio of products and services, including WheezeRate Detector, RPM Programs, and Telehealth Platforms.
FDA-cleared device for remote detection of wheezes in patients.
Customizable programs for monitoring and managing chronic conditions remotely.
HIPAA-compliant platforms for data-driven patient care and interventions.
Funding Insights of Respiri
- Total Rounds 4
- Last Round Post-IPO — $12.5M
- First Round $10.32M
(Oct 2011)
- Investors Count 1
All 4 funding rounds of Respiri with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $12.5M | Post-IPO | – | – | – |
| Mar 2020 | $2M | Post-IPO | – | – | – |
| Apr 2018 | $3M | Post-IPO | – | – | – |
| Oct 2011 | $10.32M | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Respiri
Respiri has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bergen Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bergen Asset Management is focused on global institutional investments. | – | bergenasset.com | Boca Raton, USA |
Investor details for Respiri
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Respiri
7 people are tracked at Respiri (5 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Mario Gattino | CEO & Director | Leadership |
Marjan Mikel | Ceo/managing Director | Leadership |
Samaneh Sarraf | Chief Research Officer | Leadership |
Peter Hildebrandt | Chief Operating Officer | Leadership |
George V. | Chief Technology Officer | Leadership |
Kevin Dsouza | Architect | Team |
Matt Wilp | Customer Success Executive | Team |
Complete people profiles for Respiri
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Respiri
Respiri is a publicly listed company on the ASX with ticker symbol VHL in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Jul 2000
- Listed onASX: VHL
- Listed entityVITASORA HEALTH LIMITED
- Exchange sectorHealth technology
- ISINAU0000392748
- Share price0.01 AUD (-8.33% on the day) · 2026-10-09
- Market capitalisation28,184,127.00 AUD
- EPS (diluted, trailing year)-0.01 AUD
- Volume (last session)1,591,966
Financials of Respiri
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 4.3M AUD | -10.6M AUD | -9.9M AUD |
| 2025 | 3.1M AUD | -10.7M AUD | -10.7M AUD |
| 2024 | 453,260 AUD | -7.1M AUD | -7.6M AUD |
| 2023 | 70,530 AUD | -5.8M AUD | -6.3M AUD |
| 2022 | 253,690 AUD | -6.6M AUD | -7.1M AUD |
Detailed financial statements for Respiri
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Respiri
4 dated milestones of Respiri across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Respiri is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $10.3M.
- Funding Latest funding round, Post-IPO, of $12.5M.
Competitors of Respiri
Respiri operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tytocare.com | 2011 | Netanya, Israel | $199.5M | – | Medical consultations are facilitated via self-exams and remote diagnostic devices. | |
| edwards.com | 1958 | Irvine, United States | – | 19,800 | Medical devices for structural heart disease are developed and provided. | |
| biointellisense.com | 2018 | Redwood, United States | $82M | 26 | Vital signs are monitored via a single-use patch and platform. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | |
| athelas.com | 2014 | Mountain View, United States | $135.83M | 213 | Provider of smart solutions for monitoring heart rate, weight, and blood pressure | |
| coachcare.com | 2013 | New York, United States | $60.2M | – | Remote monitoring platform for tracking patient activity | |
| lumen.me | 2014 | Ramat Hasharon, Israel | $77.5M | 1 | Breath-based metabolism tracker for personalized diet plans is provided. | |
| cardionet.com | 1999 | Conshohocken, United States | $141.9M | – | Outpatient cardiac arrhythmia monitoring solutions are provided by CardioNet. | |
| picooc.com | 2013 | Beijing, China | $46M | – | Smart body composition scales and sphygmomanometers are provided by PICOOC. | |
| somatix.com | 2015 | New York, United States | $21.24M | – | AI-based remote health monitoring tools are provided for patient care. |
Detailed competitors of Respiri
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Respiri
Complete news archive for Respiri
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Respiri
10 companies that operate in the same segment as Respiri (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Respiri
Respiri was founded in 1987 and raised its 1st funding round 24 years after it was founded.
Respiri is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Mario Gattino is the current CEO of Respiri.
Annual revenue of Respiri is $2.95M as on Jun 30, 2026.
Respiri was founded in 1987 in Melbourne, Australia, where tools for detecting respiratory disorders are developed. A range of clinical laboratory and home care products is created by the company within the medical technology sector. The SonoSentry system, an over-the-counter device for automated wheeze detection, is offered, with data upload capabilities to the cloud through a web portal. Leadership is provided by CEO and Director Mario Gattino.
Respiri's top competitors include Tyto Care, Endotronix and Athelas.
Respiri offers WheezeRate Detector, RPM Programs, and Telehealth Platforms.
Yes, Respiri is publicly traded on ASX under the ticker symbol VHL.
Respiri has 1 investor. Key investors include Bergen Asset Management.
Respiri operates through Respiri Limited.